Form 4/A for REPL Replimune Group, Inc.
Accepted 2021-07-19 00:00:00 ET · period of report 2021-01-14 · accession 0001104659-21-093670 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMA | 2021-07-19 | 2021-01-14+ | REPL | Esposito Pamela | Chief Business Off | S - Sale+OE | $43.99 | -55.0K | 176.0K | -24% | -$2.42M |
| DMA | 2021-07-19 | 2021-01-14+ | REPL | Esposito Pamela | Chief Business Off | M - OptEx | $1.01 | +55.0K | 181.7K | +43% | +$55.5K |
| DMA | 2021-07-19 | 2021-01-14+ | REPL | Esposito Pamela | Chief Business Off | M - OptEx | $0.00 | -55.0K | 108.2K | -34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-01-19 | S | D | 5,127 | $42.38 | 175,994 | D | — | — | (F3) The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.76. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. (F4) Following the sales reported on this Form 4, the reporting person continues to beneficially own 175,994 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 458,852 shares of the Issuer's common stock, 284,936 of which are exercisable as of the date hereof. The original Form 4 filed on January 19, 2021 is being amended by this Form 4 solely to correct an administrative error, which misreported the total number of options held by the reporting person and the amount exercisable as of January 19, 2021. |
| 2 | Common | Common Stock | 2021-01-19 | S | D | 600 | $43.24 | 181,121 | D | — | — | (F2) The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.88 to $43.86. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 3 | Common | Common Stock | 2021-01-15 | S | D | 29,273 | $43.58 | 175,994 | D | — | — | |
| 4 | Common | Common Stock | 2021-01-15 | M | A | 29,273 | $1.01 | 205,267 | D | — | — | |
| 5 | Common | Common Stock | 2021-01-14 | S | D | 20,000 | $45.02 | 175,994 | D | — | — | |
| 6 | Common | Common Stock | 2021-01-14 | M | A | 20,000 | $1.01 | 195,994 | D | — | — | |
| 7 | Common | Common Stock | 2021-01-19 | M | A | 5,727 | $1.01 | 181,721 | D | — | — | |
| 8 | Derivative | Employee Stock Option (right to buy) | 2021-01-19 | M | D | 5,727 | $0.00 | 73,203 | D | $1.01 · — to 2025-11-01 | 5,727 Common Stock | (F5) The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying such stock option have vested and are exercisable as of the date hereof. |
| 9 | Derivative | Employee Stock Option (right to buy) | 2021-01-15 | M | D | 29,273 | $0.00 | 78,930 | D | $1.01 · — to 2025-11-01 | 29,273 Common Stock | (F5) The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying such stock option have vested and are exercisable as of the date hereof. |
| 10 | Derivative | Employee Stock Option (right to buy) | 2021-01-14 | M | D | 20,000 | $0.00 | 108,203 | D | $1.01 · — to 2025-11-01 | 20,000 Common Stock | (F5) The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying such stock option have vested and are exercisable as of the date hereof. |